These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1114 related articles for article (PubMed ID: 28595326)
21. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A JACC Cardiovasc Interv; 2012 Jul; 5(7):718-27. PubMed ID: 22814776 [TBL] [Abstract][Full Text] [Related]
22. PCI versus CABG for multivessel coronary disease in diabetics. Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938 [TBL] [Abstract][Full Text] [Related]
23. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting. Gioia G; Matthai W; Gillin K; Dralle J; Benassi A; Gioia MF; White J Catheter Cardiovasc Interv; 2007 Jul; 70(1):26-33. PubMed ID: 17585381 [TBL] [Abstract][Full Text] [Related]
24. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471 [TBL] [Abstract][Full Text] [Related]
25. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ; Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014 [TBL] [Abstract][Full Text] [Related]
26. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease. Yang JH; Gwon HC; Cho SJ; Hahn JY; Choi JH; Choi SH; Lee YT; Lee SH; Hong KP; Park JE Ann Thorac Surg; 2008 Jan; 85(1):65-70. PubMed ID: 18154782 [TBL] [Abstract][Full Text] [Related]
27. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction. Bianco V; Kilic A; Mulukutla S; Gleason TG; Kliner D; Allen CC; Habertheuer A; Aranda-Michel E; Humar R; Navid F; Wang Y; Sultan I J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1022-1031.e5. PubMed ID: 33059935 [TBL] [Abstract][Full Text] [Related]
28. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2). Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R; Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550 [TBL] [Abstract][Full Text] [Related]
29. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials. Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779 [TBL] [Abstract][Full Text] [Related]
30. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. Head SJ; Holmes DR; Mack MJ; Serruys PW; Mohr FW; Morice MC; Colombo A; Kappetein AP; JACC Cardiovasc Interv; 2012 Jun; 5(6):618-25. PubMed ID: 22721656 [TBL] [Abstract][Full Text] [Related]
31. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery. Bangalore S; Guo Y; Samadashvili Z; Blecker S; Hannan EL Circulation; 2016 May; 133(22):2132-40. PubMed ID: 27151532 [TBL] [Abstract][Full Text] [Related]
32. Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. Ben-Gal Y; Moses JW; Mehran R; Lansky AJ; Weisz G; Nikolsky E; Argenziano M; Williams MR; Colombo A; Aylward PE; Stone GW JACC Cardiovasc Interv; 2010 Oct; 3(10):1059-67. PubMed ID: 20965465 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention. Krenn L; Kopp C; Glogar D; Lang IM; Delle-Karth G; Neunteufl T; Kreiner G; Kaider A; Bergler-Klein J; Khorsand A; Nikfardjam M; Laufer G; Maurer G; Gyöngyösi M Catheter Cardiovasc Interv; 2014 Dec; 84(7):1029-39. PubMed ID: 24403120 [TBL] [Abstract][Full Text] [Related]
34. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087 [TBL] [Abstract][Full Text] [Related]
35. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Mohr FW; Morice MC; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Morel MA; Van Dyck N; Houle VM; Dawkins KD; Serruys PW Lancet; 2013 Feb; 381(9867):629-38. PubMed ID: 23439102 [TBL] [Abstract][Full Text] [Related]
36. Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study. Garg S; Sarno G; Gutiérrez-Chico JL; Garcia-Garcia HM; Gomez-Lara J; Serruys PW; EuroIntervention; 2011 Apr; 6(9):1060-7. PubMed ID: 21518677 [TBL] [Abstract][Full Text] [Related]
38. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization. Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ JACC Cardiovasc Interv; 2010 Jun; 3(6):612-23. PubMed ID: 20630454 [TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III. Cho Y; Misumi T; Shimura S; Aki A; Furuya H; Odagiri S; Okada K; Ueda T Eur J Cardiothorac Surg; 2014 Mar; 45(3):431-7. PubMed ID: 23979988 [TBL] [Abstract][Full Text] [Related]
40. Improved long-term survival for diabetic patients with surgical versus interventional revascularization. Kurlansky P; Herbert M; Prince S; Mack MJ Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]